eamdacademy.org-LTtV-1794390061-z701222602 1794390061 Eurasian Academy of Medicine and Dentistry info@eamdacademy.org Eurasian Academy of Medicine and Dentistry Journal of Applied Pharmaceutical Technologies and Systems J Appl Pharm Technol Syst 3149-9589 2024 3 2 Ahmed Mansour Omar Saeed 2024 10.68159/z701222602 https://eamdacademy.org/pub/journal/3/article/z701222602 Vargason AM, Anselmo AC, Mitragotri S. The evolution of commercial drug delivery technologies. Nat Biomed Eng. 2021;5(9):951-67. Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20(2):101-24. Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-94. Kulkarni JA, Witzigmann D, Thomson SB, Chen S, Leavitt BR, Cullis PR, et al. The current landscape of nucleic acid therapeutics. Nat Nanotechnol. 2021;16(6):630-43. Mendes BB, Conniot J, Avital A, Yao D, Jiang X, Zhou X, et al. Nanodelivery of nucleic acids. Nat Rev Methods Primers. 2022;2(1):24. Ghezzi M, Pescina S, Padula C, Santi P, Del Favero E, Cantù L, et al. Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions. J Control Release. 2021;332:312-36. Sun T, Jiang C. Stimuli-responsive drug delivery systems triggered by intracellular or subcellular microenvironments. Adv Drug Deliv Rev. 2023;196:114773. Trenfield SJ, Awad A, Goyanes A, Gaisford S, Basit AW. 3D printing pharmaceuticals: Drug development to frontline care. Trends Pharmacol Sci. 2018;39(5):440-51. Hwang D, Ramsey JD, Kabanov AV. Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. Adv Drug Deliv Rev. 2020;156:80-118. Li S, Jiang Q, Liu S, Zhang Y, Tian Y, Song C, et al. A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo. Nat Biotechnol. 2018;36(3):258-64. Manikkath J, Subramony JA. Toward closed-loop drug delivery: Integrating wearable technologies with transdermal drug delivery systems. Adv Drug Deliv Rev. 2021;179:113997. Kim J, Campbell AS, de Ávila BE, Wang J. Wearable biosensors for healthcare monitoring. Nat Biotechnol. 2019;37(4):389-406. Anselmo AC, Mitragotri S. Nanoparticles in the clinic: An update. Bioeng Transl Med. 2019;4(3):e10143. Wang S, Cheng K, Chen K, Xu C, Ma P, Dang G, et al. Nanoparticle-based medicines in clinical cancer therapy. Nano Today. 2022;45:101512. Jiang Q, Liu S, Liu J, Wang ZG, Ding B. Rationally designed DNA origami nanomaterials for drug delivery in vivo. Adv Mater. 2019;31(45):1804785. Fayzullin A, Bakulina A, Mikaelyan K, Shekhter A, Guller A. Implantable drug delivery systems and foreign body reaction: Traversing the current clinical landscape. Bioengineering (Basel). 2021;8(12):205. Cheng Q, Wei T, Farbiak L, Johnson LT, Dilliard SA, Siegwart DJ. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing. Nat Nanotechnol. 2020;15(4):313-20. Awad A, Trenfield SJ, Gaisford S, Basit AW. 3D printed medicines: A new branch of digital healthcare. Int J Pharm. 2018;548(1):586-96. Tregubov AA, Nikitin PI, Nikitin MP. Advanced smart nanomaterials with integrated logic-gating and biocomputing: Dawn of theranostic nanorobots. Chem Rev. 2018;118(20):10294-348. Weiden J, Bastings MMC. DNA origami nanostructures for controlled therapeutic drug delivery. Curr Opin Colloid Interface Sci. 2021;52:101411. Samaridou E, Heyes J, Lutwyche P. Lipid nanoparticles for nucleic acid delivery: Current perspectives. Adv Drug Deliv Rev. 2020;154-155:37-63. Paunovska K, Loughrey D, Dahlman JE. Drug delivery systems for RNA therapeutics. Nat Rev Genet. 2022;23(5):265-80. Cheng Q, Wei T, Jia Y, Farbiak L, Zhou K, Zhang S, et al. Dendrimer-based lipid nanoparticles deliver therapeutic FAH mRNA to normalize liver function and extend survival in a mouse model of hepatorenal tyrosinemia type I. Adv Mater. 2018;30(52):e1805308. Kroll AV, Fang RH, Zhang L. Biointerfacing and applications of cell membrane-coated nanoparticles. Bioconjug Chem. 2017;28(1):23-32. Luo C, He L, Chen F, Fu T, Zhang P, Xiao Z, et al. Stimulus-responsive nanomaterials containing logic gates for biomedical applications. Cell Rep Phys Sci. 2021;2(2):100387. Wang Y, Lu X, Wu X, Li Y, Tang W, Yang C, et al. Chemically modified DNA nanostructures for drug delivery. Innovation (Camb). 2022;3(2):100214. Tang L, Yang Z, Zhou Z, Ma Y, Kiesewetter DO, Wang Z, et al. A logic-gated modular nanovesicle enables programmable drug release for on-demand chemotherapy. Theranostics. 2019;9(5):1358-74. Badeau BA, Comerford MP, Arakawa CK, Shadish JA, DeForest CA. Engineered modular biomaterial logic gates for environmentally triggered therapeutic delivery. Nat Chem. 2018;10(3):251-8. Wagenbauer KF, Pham N, Gottschlich A, Kick B, Kozina V, Frank C, et al. Programmable multispecific DNA-origami-based T-cell engagers. Nat Nanotechnol. 2023;18(11):1319-26. Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019;18(3):175-96. Barenholz Y. Doxil®—The first FDA-approved nano-drug: From an idea to a product. In: Torchilin VP, editor. Handbook of Harnessing Biomaterials in Nanomedicine. Singapore: Jenny Stanford Publishing; 2021. p. 463-528. Mehta M, Bui TA, Yang X, Aksoy Y, Goldys EM, Deng W. Lipid-based nanoparticles for drug/gene delivery: An overview of the production techniques and difficulties encountered in their industrial development. ACS Mater Au. 2023;3(6):600-19. Duan L, Ouyang K, Xu X, Xu L, Wen C, Zhou X, et al. Nanoparticle delivery of CRISPR/Cas9 for genome editing. Front Genet. 2021;12:673286. Aghamiri S, Talaei S, Ghavidel AA, Zandsalimi F, Masoumi S, Hafshejani NH, et al. Nanoparticles-mediated CRISPR/Cas9 delivery: Recent advances in cancer treatment. J Drug Deliv Sci Technol. 2020;56:101533. Ezike TC, Okpala US, Onoja UL, Nwike CP, Ezeako EC, Okpara OJ, et al. Advances in drug delivery systems, challenges and future directions. Heliyon. 2023;9(6):e17488.